Loading...
  • Syndrome
  • Background Human Immunodeficiency Syndrome (HIV) is a major source of concern in the Turks and Caicos Islands (TCI), a small archipelago of islands in the Caribbean region. (bmj.com)
  • Treatment
  • Moreover, willingness to disclose HIV seropositivity was related to having one or less sexual partner (OR = 1.98, 95% CI = 1.29 - 3.01), non-regular church attendance (OR = 1.55, 95% CI = 1.10 - 2.19), cohabitation (OR = 0.67, 95% CI = 0.47 - 0.97), knowing about HIV treatment (OR = 0.50, 95% CI = 0.32 - 0.80) and having an HIV test (OR = 0.43, 95% CI = 0.26 - 0.63). (bmj.com)
  • Seroposite HIV patients that take their treatment at the Clinical Hospital of The Federal University of Goias, and have their records in the hospital. (clinicaltrials.gov)
  • Anal warts have a high prevalence and recurrence and usually require extended lengths of treatment and follow-up, especially in the HIV population. (clinicaltrials.gov)
  • Very little is known about the best treatment course for neurosyphilis in patients who are also infected with HIV. (clinicaltrials.gov)
  • Results
  • The results from this study, using healthy volunteers, will be compared to those in another study of HIV-infected patients. (clinicaltrials.gov)
  • The content of text messages will have a maximum of 160 characters and not mention HIV and will state the dates for the forthcoming consultations, visits to the pharmacy, lab results, time to take medication and reminders for patients who miss appointments. (clinicaltrials.gov)
  • adults
  • A Single Center, Open Label, Longitudinal Single Arm Study to Compare the Efficacy and Safety of Prophylactic Famciclovir 500 mg b.d. in HIV Positive Adults With Recurrent Genital Herpes. (clinicaltrials.gov)
  • study
  • This information will be compared to that of HIV patients in another study. (clinicaltrials.gov)
  • The purposes of this study are to determine whether Carraguard® Gel can prevent the transmission of HIV when used during vaginal intercourse, and to confirm that the gel is safe for vaginal use. (clinicaltrials.gov)
  • This study is designed to show if Carraguard® can protect women against HIV if it is used before sex, and is safe for long-term use. (clinicaltrials.gov)
  • The purpose of this study is to see whether changes in diet and behavior lessen the number of times HIV-positive people get diarrhea (soft or loose stools). (clinicaltrials.gov)
  • provide
  • The sponsor must provide the capacity for differential confirmatory testing for those who develop vaccine-induced seropositivity. (nzdl.org)
  • risk
  • Being Black or Hispanic and having shared needles in New York City appear to be factors associated with increased risk for HIV positivity in Ohio. (cdc.gov)
  • test
  • These findings may have implications on post HIV test counselling initiatives, which should include a focus on education. (bmj.com)
  • CD4-IgG is capable of binding to HIV envelope protein (gp120) and inhibiting HIV infectivity in test tube studies. (clinicaltrials.gov)